Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | -9 |
| Ticker | RAC |
| Latest Price | 1.15 AUD as of close on 04-Jul-2025 |
| 3 Month price range | 0.93 to 1.45 AUD |
| Market Capitalisation | 206.76Mn AUD |
| Country | Australia |
| Region | Asia |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Race Oncology Limited, a clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments. The company's lead product is bisantrene, a small molecule chemotherapeutic that has a clinical history with demonstrated therapeutic benefits in adult and paediatric patients. It is advancing reformulated bisantrene (RC220) to address the unmet need of patients across various oncology indications with a clinical focus on anthracycline combination to deliver cardioprotection and enhanced anticancer activity in solid tumors. The company is also exploring RC220 as a low intensity treatment for acute myeloid leukaemia. In addition, it is investigating the effect of bisantrene on the m6A RNA pathway, following independent research identifying bisantrene as the potent inhibitor of fat mass and obesity-associated protein. The company has collaborations with Astex, City of Hope, MD Anderson, Sheba City of Health, UNC School of Medicine, University of Wollongong, and University of Newcastle. The company was formerly known as Coronado Resources Limited. Race Oncology Limited was incorporated in 2011 and is headquartered in Sydney, Australia. See More ... |
| Company URL | https://www.raceoncology.com |
| See Darwins Full Analysis for Race Oncology Ltd |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Race Oncology Ltd. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -10 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +1 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | 0 |
There are 3 live alerts for Race Oncology Ltd. All the alerts are negative.
There are 12 peers of Race Oncology Ltd.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Argenica Therapeutics Ltd (AGN) | Biotechnology | -2.0 | +22 |
| Arovella Therapeutics Ltd (ALA) | Biotechnology | +19.2 | +2 |
| CSL Ltd (CSL) | Biotechnology | -2.1 | +19 |
| Clinuvel Pharmaceuticals Ltd (CUV) | Biotechnology | -1.9 | +7 |
| Imugene Ltd (IMU) | Biotechnology | -23.7 | -9 |
| Mesoblast Ltd (MSB) | Biotechnology | -7.9 | -10 |
| Opthea Ltd (OPT) | Biotechnology | 0 | -12 |
| PYC Therapeutics Ltd (PYC) | Biotechnology | +9.1 | +24 |
| Paradigm Biopharmaceuticals Ltd (PAR) | Biotechnology | +49.2 | +18 |
| Polynovo Ltd (PNV) | Biotechnology | -9.1 | +2 |
| Telix Pharmaceuticals Ltd (TLX) | Biotechnology | -11.9 | +7 |
| Tissue Repair Ltd (TRP) | Biotechnology | +16.2 | -10 |
To see complete information on Race Oncology Ltd or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |